LEXINGTON, Mass. and Bangalore, India, January 21, 2015 (GLOBENEWSWIRE) — Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of
ESPOO, Finland and BANGALORE, India, June 24, 2014 /PRNewswire/ — Orion Corporation, a globally operating Finnish pharmaceuticals company and Aurigene, a leading biotech company based in India, today announced that
Aurigene to participate in a conference organised by Royal Society of Chemistry, "Overcoming the Bottlenecks in Drug Discovery and Development" to be held on 20 – 21 March 2014 at Ranbaxy, Gurgaon, India. Conference
Aurigene to participate in 26th EORTC – NCI – AACR Sympsoium on Molecular Targets in Cancer Therapeutics to be held in Barcelona, Spain from 18-21 November, 2014.